MKI67 and neoplasm: As Ki-67 possibly impacts treatment outcome (Arnold et al. 2005, Palazzo et al. 2013, Ezziddin et al. 2014, Panzuto et al. 2014b, Albertelli et al. 2021), we hypothesized a lower efficacy in G2 tumours.